Preclinical efficacy of NXP900, a YES1/SRC kinase inhibitor in esophageal squamous cancer models.

Sweta Dash, Katherine Nyswaner, Mungo J.B. Harvey, Ben King, Allison Woods, Neil O. Carragher, Asier Unciti, Enrique Poradosu, John Brognard

Research output: Contribution to journalMeeting abstract

Original languageEnglish
Pages (from-to)e15133-e15133
JournalJournal of Clinical Oncology
Volume41
Issue number16_suppl
DOIs
Publication statusPublished - 31 May 2023

Cite this